Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate how BLI-489 and piperacillin interact when given together to healthy subjects.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT07059858 · Intellectual Disability, Healthy Subjects
NCT07102251 · Healthy Subjects
NCT06342713 · Healthy Participants, Healthy Subjects, and more
NCT06014515 · Healthy Subjects, Cardiovascular Disease
NCT07181369 · Healthy Subjects, Cold Urticaria, and more
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions